Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1967]
News [3163]
Articles [130]
Editorials [3]
Conferences [121]
elearning [17]
Combination therapy for high-risk MDS? Not quite yet
Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA
Combination therapy for high-risk MDS? Not quite yet ( Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA )
8 Dec 2014
Should young adults with acute lymphocytic leukaemia receive paediatric...
Dr Wendy Stock - University of Chicago, Chicago, USA
Should young adults with acute lymphocytic leukaemia receive paediatric treatment protocols? ( Dr Wendy Stock - University of Chicago, Chicago, USA )
8 Dec 2014
Results of HD2000 trial comparing combination therapies in advanced-stage...
Prof Massimo Federico - University of Modena and Reggio Emilia, Modena, Italy
Results of HD2000 trial comparing combination therapies in advanced-stage Hodgkin's lymphoma ( Prof Massimo Federico - University of Modena and Reggio Emilia, Modena, Italy )
8 Dec 2014
Characterising the findings of the peripheral T-cell lymphoma registry
Prof Massimo Federico - University of Modena and Reggio Emilia, Modena, Italy
Characterising the findings of the peripheral T-cell lymphoma registry ( Prof Massimo Federico - University of Modena and Reggio Emilia, Modena, Italy )
8 Dec 2014
ASH 2014: Highlights in mantle cell lymphoma
Prof Steven Le Gouill and Prof Simon Rule
ASH 2014: Highlights in mantle cell lymphoma ( Prof Steven Le Gouill and Prof Simon Rule )
8 Dec 2014
ASH 2014: Highlights in multiple myeloma
Prof Philippe Moreau, Prof Keith Stewart, Prof Marivi Mateos, Prof Meletios...
ASH 2014: Highlights in multiple myeloma ( Prof Philippe Moreau, Prof Keith Stewart, Prof Marivi Mateos, Prof Meletios Dimopoulos )
8 Dec 2014
Tyrosine kinase inhibitor in combination with chemo shows benefit in acute...
Dr Christoph Röllig - University Hospital Dresden, Dresden, Germany
Tyrosine kinase inhibitor in combination with chemo shows benefit in acute myeloid leukaemia ( Dr Christoph Röllig - University Hospital Dresden, Dresden, Germany )
7 Dec 2014
New cytarabine combinations could overcome toxicities in AML treatment
Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA
New cytarabine combinations could overcome toxicities in AML treatment ( Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA )
7 Dec 2014
Paediatric leukaemia treatment regimens lead to improved outcomes in...
Dr Wendy Stock - University of Chicago, Chicago, USA
Paediatric leukaemia treatment regimens lead to improved outcomes in adolescents and young adults ( Dr Wendy Stock - University of Chicago, Chicago, USA )
7 Dec 2014
Targeted therapy effective in elderly patients with Philadelphia-positive acute...
Dr Oliver Ottmann - Goethe University, Frankfurt, Germany
Targeted therapy effective in elderly patients with Philadelphia-positive acute lymphocytic leukaemia ( Dr Oliver Ottmann - Goethe University, Frankfurt, Germany )
7 Dec 2014
Children with rare leukaemia have better-than-expected outcomes after tailored...
Dr Brent Wood - Seattle Children's Hospital, Seattle, USA
Children with rare leukaemia have better-than-expected outcomes after tailored treatment ( Dr Brent Wood - Seattle Children's Hospital, Seattle, USA )
7 Dec 2014
First randomised evidence for benefit from adding a tyrosine kinase inhibitor...
Dr Christoph Röllig - University Hospital Dresden, Dresden, Germany
First randomised evidence for benefit from adding a tyrosine kinase inhibitor in acute myeloid leukaemia ( Dr Christoph Röllig - University Hospital Dresden, Dresden, Germany )
7 Dec 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation